Evidence map›Paper›PMID 30717739›Full record

ReviewMicrobial cell factories2019

Systems metabolic engineering for citric acid production by Aspergillus niger in the post-genomic era.

Zhenyu Tong, Xiaomei Zheng, Yi Tong, Yong-Cheng Shi, Jibin Sun

Abstract readReview
In one paragraph

Review in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Recent advances and future directions on GLA-producing organisms.Frontiers in bioengineering and biotechnology · 2025
    Review
  12. Article
  13. Control ofFoods (Basel, Switzerland) · 2024
    Article
  14. The forced activation of asexual conidiation inSynthetic and systems biotechnology · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Genome-wide transcription landscape of citric acid producingFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenyu TongDepartment of Grain Science and Industry, Kansas State University, Manhattan, KS, 66506, USA.
Xiaomei ZhengTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, People's Republic of China.ORCID http://orcid.org/0000-0001-9136-0666
Yi TongCOFCO Biochemical (Anhui) Co. Ltd, Bengbu, 233000, People's Republic of China.
Yong-Cheng ShiDepartment of Grain Science and Industry, Kansas State University, Manhattan, KS, 66506, USA.
Jibin SunTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, People's Republic of China. sun_jb@tib.cas.cn.

Funding

National Natural Science Foundation of China 31370113National Natural Science Foundation of China 31700085
6 · The paper itself

Abstract

Citric acid is the world's largest consumed organic acid and is widely used in beverage, food and pharmaceutical industries. Aspergillus niger is the main industrial workhorse for citric acid production. Since the release of the genome sequence, extensive multi-omic data are being rapidly obtained, which greatly boost our understanding of the citric acid accumulation mechanism in A. niger to a molecular and system level. Most recently, the rapid development of CRISPR/Cas9 system facilitates highly efficient genome-scale genetic perturbation in A. niger. In this review, we summarize the impact of systems biology on the citric acid molecular regulatory mechanisms, the advances in metabolic engineering strategies for enhancing citric acid production and discuss the development and application of CRISPR/Cas9 systems for genome editing in A. niger. We believe that future systems metabolic engineering efforts will redesign and engineer A. niger as a highly optimized cell factory for industrial citric acid production.

Indexed as

Genome, FungalMetabolic EngineeringAspergillus nigerCitric AcidCRISPR-Cas SystemsGene EditingGenomicsIndustrial MicrobiologySystems BiologyCitric AcidAspergillus nigerCitric acidCRISPR/Cas9 genome editingMetabolic engineeringSystems biology

Identifiers

PMID30717739
PMCPMC6362574

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.